In this study, we corroborate that T-ALL patients with high NFE2L2 levels exhibit genetic programs specifically related to MAPK-ERK and PI3K-AKT-mTOR signalling pathways. The gene discussed is MTOR; the disease is acute lymphoblastic leukemia.